This site is intended for health professionals only
Wednesday 21 November 2018
Share |

Topic: Brexit

November 15, 2018
Matt Hancock made the comments during a five-hour cabinet meeting discussing the Brexit deal negotiated with the EU by Prime Minister Theresa May, according to The Times

The UK's health minister told cabinet members he could not guarantee there would be no deaths if Britain exits the European Union (EU) without a deal, The Times newspaper has reported.
 
Matt Hancock made the comments during a five-hour cabinet meeting discussing the Brexit deal negotiated with the EU by Prime Minister Theresa May, according to the newspaper.
 

November 8, 2018
UK building ‘refrigeration capacity’ in case of Brexit drug shortages

The UK's health secretary has said that the Government is building extra "refrigeration capacity" in case a no-deal Brexit leaves the country short of certain medicines.
 
Speaking to ITV’s Peston show, Matt Hancock urged patients not to stockpile medicines, and said the Government is working with the pharmaceutical industry to ensure patients are able to obtain necessary medication.
 

October 25, 2018
Six-week no-deal Brexit drugs stockpile could take over a year to prepare

Stockpiling six weeks worth of medicines after a no-deal Brexit could take over a year due to creating extra storage for drugs that need to be kept in certain conditions, a Government committee has heard.
 
Speaking before the Health and Social Care Committee on Tuesday [23 October], wholesalers’ body the Healthcare Distribution Association (HDA) executive director Martin Sawer explained that building new cold-chain warehouses for medicines that need refrigeration might take more than a year.
 

July 18, 2018
Up to 42% of UK medicines may not be able to market their products in the European Union (EU) post-Brexit, a survey from the European Medicines Agency (EMA) has revealed.

Up to 42% of UK medicines may not be able to market their products in the European Union (EU) post-Brexit, a survey from the European Medicines Agency (EMA) has revealed.
 
The EMA said marketing authorisation holders for 58% of 693 centrally authorised products (CAPs) are on track to ensure they can continue to market their products once the UK leaves the EU in March 2019.
 

November 9, 2017
The survey highlighted that medicines used by patients across Europe have integrated supply chains

EFPIA has published results of a survey underlining the sheer scale and importance of the medicines issues that must be addressed as part of the Brexit discussions in order to protect public health.

 

Commenting on the survey, EFPIA Director General, Nathalie Moll said. “The survey underlines the  scale of the task ahead. For life saving and life improving medicines, the EU and UK cannot afford to wait any longer to ensure that the necessary cooperation on medicines is in place from the day the UK leaves the EU.”

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine